These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 18212601

  • 1. Augmentation of antidepressants with atypical antipsychotics: a review of the current literature.
    Philip NS, Carpenter LL, Tyrka AR, Price LH.
    J Psychiatr Pract; 2008 Jan; 14(1):34-44. PubMed ID: 18212601
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A model of anticholinergic activity of atypical antipsychotic medications.
    Chew ML, Mulsant BH, Pollock BG, Lehman ME, Greenspan A, Kirshner MA, Bies RR, Kapur S, Gharabawi G.
    Schizophr Res; 2006 Dec; 88(1-3):63-72. PubMed ID: 16928430
    [Abstract] [Full Text] [Related]

  • 4. Second-generation antipsychotics for major depressive disorder and dysthymia.
    Komossa K, Depping AM, Gaudchau A, Kissling W, Leucht S.
    Cochrane Database Syst Rev; 2010 Dec 08; (12):CD008121. PubMed ID: 21154393
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y, Kim E, You M, Pikalov A, Tran QV.
    J Med Econ; 2009 Jun 08; 12(2):104-13. PubMed ID: 19527195
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
    Perlis RH.
    Am J Manag Care; 2007 Nov 08; 13(7 Suppl):S178-88. PubMed ID: 18041879
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The use of novel antipsychotics in the older patient with neurodegenerative disorders in the long-term care setting.
    Kasckow JW, Mulchahey JJ, Mohamed S.
    J Am Med Dir Assoc; 2004 Nov 08; 5(4):242-8. PubMed ID: 15228634
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
    Cruz N, Sanchez-Moreno J, Torres F, Goikolea JM, Valentí M, Vieta E.
    Int J Neuropsychopharmacol; 2010 Feb 08; 13(1):5-14. PubMed ID: 19638254
    [Abstract] [Full Text] [Related]

  • 14. Use of atypical antipsychotics in refractory depression and anxiety.
    Nemeroff CB.
    J Clin Psychiatry; 2005 Feb 08; 66 Suppl 8():13-21. PubMed ID: 16336032
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.
    Lorenz RA, Jackson CW, Saitz M.
    Pharmacotherapy; 2010 Sep 08; 30(9):942-51. PubMed ID: 20795849
    [Abstract] [Full Text] [Related]

  • 19. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
    Taylor DM, Cornelius V, Smith L, Young AH.
    Acta Psychiatr Scand; 2014 Dec 08; 130(6):452-69. PubMed ID: 25283309
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.